Evidence map›Paper›PMID 25036610›Full record

ArticleNeuropharmacology2014

Permanent suppression of cortical oscillations in mice after adolescent exposure to cannabinoids: receptor mechanisms.

Sylvina M Raver, Asaf Keller

Abstract read
In one paragraph

Article in Neuropharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Review
  3. Perinatal Fentanyl Exposure Leads to Long-Lasting Impairments in Somatosensory Circuit Function and Behavior.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2021
    Article
  4. Review
  5. Review
  6. Review
  7. Adolescent Cannabinoid and Nicotine Exposure Differentially Alters Adult Nicotine Self-Administration in Males and Females.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2020
    Article
  8. Review
  9. Long-term hippocampal interneuronopathy drives sex-dimorphic spatial memory impairment induced by prenatal THC exposure.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2020
    Article
  10. Adolescent ΔFrontiers in psychiatry · 2020
    Article
  11. Article
  12. Cannabinoid disruption of learning mechanisms involved in reward processing.Learning & memory (Cold Spring Harbor, N.Y.) · 2018
    Review
  13. Emerging Mechanisms Underlying Dynamics of GABAergic Synapses.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Cannabinoids and Epilepsy.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2015
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Sylvina M RaverProgram in Neuroscience and Department of Anatomy and Neurobiology, University of Maryland School of Medicine, 20 Penn St. HSF II S241, Baltimore, MD 21201, USA.
Asaf KellerProgram in Neuroscience and Department of Anatomy and Neurobiology, University of Maryland School of Medicine, 20 Penn St. HSF II S241, Baltimore, MD 21201, USA. Electronic address: asafkeller@fastmail.us.
University of Maryland, Baltimore · US

Funding

Adolescent marijuana use and maturation of cortical functionsF31DA031547 · NIDA · UNIVERSITY OF MARYLAND BALTIMORE · PI RAVER, SYLVINA MULLINS · 2011 to 2013
$93k
NIDA NIH HHS F31 DA031547NIDA NIH HHS F31DA031547
6 · The paper itself

Abstract

Marijuana use in adolescence, but not adulthood, may permanently impair cognitive functioning and increase the risk of developing schizophrenia. Cortical oscillations are patterns of neural network activity implicated in cognitive processing, and are abnormal in patients with schizophrenia. We have recently reported that cortical oscillations are suppressed in adult mice that were treated with the cannabinoids WIN55,212-2 (WIN) or Δ(9)tetrahydrocannabinol (THC) in adolescence, but not adulthood. WIN and THC are cannabinoid-1 (CB1R) and CB2R agonists, and also have activity at non-cannabinoid receptor targets. However, as acute WIN and THC administration can suppress oscillations through CB1Rs, we hypothesize that a similar mechanism underlies the permanent suppression of oscillations by repeated cannabinoid exposure in adolescence. Here we test the prediction that cannabinoid exposure in adolescence permanently suppresses cortical oscillations by acting through CB1Rs, and that these suppressive effects can be antagonized by a CB1R antagonist. We treated adolescent mice with various cannabinoid compounds, and pharmacologically-evoked oscillations in local field potentials (LFPs) in vitro in adults. We find that WIN exposure for six days in early adolescence suppresses oscillations preferentially in adult medial prefrontal cortex (mPFC) via CB1Rs, and that a similar CB1R mechanism accounts for the suppressive effects of long-term (20 day) adolescent THC in adult somatosensory cortex (SCx). Unexpectedly, we also find that CB2Rs may be involved in the suppression of oscillations in both mPFC and SCx by long-term adolescent cannabinoid exposure, and that non-cannabinoid receptors may also contribute to oscillation suppression in adult mPFC. These findings represent a novel attempt to antagonize the effects of adolescent cannabinoid exposure on neural network activity, and reveal the contribution of non-CB1R targets to the suppression of cortical oscillations.

Indexed as

AnimalsBenzoxazinesCannabinoid Receptor ModulatorsDronabinolIndolesMaleMiceMorpholinesNaphthalenesPiperidinesPrefrontal CortexPyrazolesReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2Somatosensory CortexTissue Culture Techniques(3R)-((2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl))methanoneAM 251AM4113BenzoxazinesCannabinoid Receptor ModulatorsDronabinolIndolesiodopravadolineMorpholinesNaphthalenesPiperidinesPyrazolesReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2DevelopmentMarijuanaNeural synchronySchizophrenia

Identifiers

PMID25036610
PMCPMC4188721
OpenAlexW2046846613

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.